Treatment of Vitamin B12 Deficiency
Treat vitamin B12 deficiency immediately with intramuscular hydroxocobalamin 1 mg, with the regimen determined by presence or absence of neurological involvement, followed by lifelong maintenance therapy every 2-3 months. 1
Initial Treatment Algorithm
Step 1: Assess for Neurological Involvement
Before initiating treatment, evaluate for neurological symptoms including:
- Unexplained sensory symptoms (pins and needles, numbness, paraesthesia)
- Motor symptoms and gait disturbances
- Balance issues and falls from impaired proprioception
- Cognitive difficulties ("brain fog," memory loss)
- Visual problems related to optic nerve dysfunction 2
Critical Warning: Do not give folic acid first, as it may mask underlying B12 deficiency and precipitate subacute combined degeneration of the spinal cord 1.
Step 2: Choose Treatment Regimen Based on Neurological Status
WITH Neurological Involvement:
- Loading phase: Hydroxocobalamin 1 mg intramuscularly on alternate days until there is no further improvement
- Maintenance: Hydroxocobalamin 1 mg intramuscularly every 2 months lifelong
- Urgent action required: Seek immediate specialist advice from neurologist and haematologist 1
WITHOUT Neurological Involvement:
- Loading phase: Hydroxocobalamin 1 mg intramuscularly three times per week for 2 weeks
- Maintenance: Hydroxocobalamin 1 mg intramuscularly every 2-3 months lifelong 1
Alternative Oral Therapy Considerations
While intramuscular therapy is the guideline-recommended standard, oral vitamin B12 can be considered in specific circumstances:
Oral therapy may be appropriate when:
- Deficiency is purely dietary in origin (vegans, vegetarians)
- No malabsorption is present
- No neurological involvement exists
- Patient compliance is assured 3, 4
Oral dosing: 1,000-2,000 mcg daily 5, 3
Important caveat: For malabsorption conditions (pernicious anemia, post-bariatric surgery, atrophic gastritis), oral supplementation is likely insufficient and parenteral therapy is strongly preferred 6. Up to 50% of patients with malabsorption require individualized injection regimens with more frequent administration to remain symptom-free 6.
Key Clinical Pitfalls to Avoid
Never delay treatment when clinical suspicion is high, even if test results are borderline or pending. Neurological damage can become irreversible 1, 2, 4.
Do not use biomarkers to titrate injection frequency after initiating treatment. Clinical response and symptom resolution should guide management, not serum B12 or methylmalonic acid levels 6.
Always exclude B12 deficiency before treating folate deficiency to prevent precipitating neurological complications 1.
Recognize that oral therapy cannot safely replace injections in malabsorption cases, despite patient preference 6.
Special Populations
Post-bariatric surgery patients: Require lifelong maintenance with 1 mg intramuscularly every 2-3 months after initial loading, as malabsorption is permanent 1.
Metformin users: Have 7-11% absolute risk of B12 deficiency and require monitoring 3.
Pregnant/breastfeeding women: Require prompt treatment as deficiency can cause developmental issues in infants; standard intramuscular regimens apply 2.
Treatment Response Expectations
- Hematological recovery: Rapid improvement within days to weeks
- Neurological recovery: May take months; delayed treatment can result in permanent sequelae despite biochemical correction 7
- Symptom resolution: Variable and individualized; some patients require more frequent injections (ranging from twice weekly to every 2-4 weeks) to remain symptom-free 6
The evidence consistently supports immediate intramuscular treatment as the safest approach to prevent irreversible neurological damage, with lifelong maintenance required for most causes of B12 deficiency.